Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Surgery. 2010 Oct;148(4):876-80; discussion 881-2. doi: 10.1016/j.surg.2010.07.010. Epub 2010 Aug 14.
Esophagogastroduodenoscopy (EGD) is commonly used in the diagnosis and treatment of gastrointestinal (GI) disorders. Our aim was to define the risk of perforation associated with EGD and identify patients who required operative intervention.
We retrospectively reviewed 72 patients from our institution plus 5 transferred patients who sustained EGD-associated perforations from January 1996 through July 2008. Percutaneous endoscopic gastrostomy, endoscopic ultrasonography, endoscopic retrograde cholangiopancreatography, transthoracic echocardiography, and concurrent colonoscopy procedures were excluded.
Perforations in 72 of 217,507 EGD procedures were identified (incidence, 0.033%); 124,844 EGDs included an interventional procedure and 92,663 were examination only. The incidence of perforation was similar whether an interventional procedure was performed or not (0.040% vs 0.029%; P = .181). The esophagus was injured most commonly (51%), followed by the duodenum (32%), jejunum (6%), stomach (3%), and common bile duct (3%). Overall mortality after perforation was 17% with a morbidity rate of 40%. Thirty-eight patients (49%) were initially treated nonoperatively, 7 of whom (18%) failed nonoperative management. The only factors we could determine that were associated with failure were free fluid or contrast extravasation on computed tomography (75% vs 23% [P < .005] and 33% vs 0% [P = .047], respectively). The morbidity of failures was equivalent to those who underwent initial operative management (63% vs 61%; P = .917), with mortality seeming to be greater (43% vs 21%; P = .09).
EGD is safe in the majority of patients; however, iatrogenic perforation is associated with considerable morbidity and mortality. Nonoperative management of GI perforation can be successful if there is no evidence of contrast extravasation or free fluid on radiographic studies. If nonoperative management fails, the outcomes may be worse than those treated initially with operative repair.
食管胃十二指肠镜检查(EGD)常用于胃肠道(GI)疾病的诊断和治疗。我们的目的是确定与 EGD 相关的穿孔风险,并确定需要手术干预的患者。
我们回顾性分析了 1996 年 1 月至 2008 年 7 月期间我院的 72 例患者和 5 例转院患者的 EGD 相关穿孔病例。排除了经皮内镜胃造口术、内镜超声检查、内镜逆行胰胆管造影术、经胸超声心动图和同期结肠镜检查。
在 217507 例 EGD 检查中发现穿孔 72 例(发生率 0.033%);124844 例 EGD 包括介入治疗,92663 例为单纯检查。无论是否进行介入治疗,穿孔的发生率相似(0.040%对 0.029%;P=0.181)。食管最常受损(51%),其次是十二指肠(32%)、空肠(6%)、胃(3%)和胆总管(3%)。穿孔后总死亡率为 17%,发病率为 40%。38 例(49%)患者最初接受非手术治疗,其中 7 例(18%)非手术治疗失败。我们唯一能确定与失败相关的因素是 CT 上有无游离液体或造影剂外渗(75%比 23%[P<0.005]和 33%比 0%[P=0.047])。失败患者的发病率与初始手术治疗患者相当(63%比 61%;P=0.917),死亡率似乎更高(43%比 21%;P=0.09)。
在大多数患者中,EGD 是安全的;然而,医源性穿孔与相当大的发病率和死亡率相关。如果放射学检查没有造影剂外渗或游离液体,非手术治疗 GI 穿孔可以成功。如果非手术治疗失败,其结果可能比最初用手术修复更差。